FOLH1 and neoplasm: Moreover, tumor uptake in PSMA-positive LNCaP xenografts described in literature for PSMA-11, PSMA-617 and PSMA-I&T range from 5-11% ID/g at 1 hr p.i., indicating a similar performance of N064 to preexisting ligands.